Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bostwick

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
BJU International|October 2, 2012
Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpointPeter Grimm, Ignace Billiet, David Bostwick
Virchows Archiv : an International Journal of Pathology|October 31, 2025
The consensus conference: pitfalls and problemsBrett Delahunt, Hemamali Samaratunga, David Bostwick, et al.
Virchows Archiv : an International Journal of Pathology|June 5, 2026
Reply to Varma et al. regarding building consensus in medicine: issues and potential solutionsBrett Delahunt, Hemamali Samaratunga, David Bostwick, et al.
The Journal of Urology|September 23, 2003
Prostate cancer grade assignment: the effect of chronological, interpretive and translation biasFilippos I Kondylis, Richard P Moriarty, David Bostwick, et al.
Journal of Oncology|September 18, 2010
Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapyMichael Dattoli, Kent Wallner, Lawrence True, et al.
The Journal of Urology|November 11, 2005
The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledgeGerald Andriole, David Bostwick, Francisco Civantos, et al.
Journal of Chemical Ecology|April 6, 2006
Chemical defenses promote persistence of the aquatic plant Micranthemum umbrosumJohn D Parker, Dwight O Collins, Julia Kubanek, et al.
The Journal of Urology|January 10, 2004
Comprehensive evaluation of ureteral healing after electrosurgical endopyelotomy in a porcine model: original report and review of the literatureCassio R Andreoni, Hsueh-Kung Lin, Ephrem Olweny, et al.
The Journal of Urology|August 8, 2006
Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trialDavid Price, Barry Stein, Paul Sieber, et al.
The Journal of Urology|September 17, 2004
Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trialGerald Andriole, David Bostwick, Otis Brawley, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
BJU International|October 2, 2012
Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpointPeter Grimm, Ignace Billiet, David Bostwick
Virchows Archiv : an International Journal of Pathology|October 31, 2025
The consensus conference: pitfalls and problemsBrett Delahunt, Hemamali Samaratunga, David Bostwick, et al.
Virchows Archiv : an International Journal of Pathology|June 5, 2026
Reply to Varma et al. regarding building consensus in medicine: issues and potential solutionsBrett Delahunt, Hemamali Samaratunga, David Bostwick, et al.
The Journal of Urology|September 23, 2003
Prostate cancer grade assignment: the effect of chronological, interpretive and translation biasFilippos I Kondylis, Richard P Moriarty, David Bostwick, et al.
Journal of Oncology|September 18, 2010
Long-term outcomes for patients with prostate cancer having intermediate and high-risk disease, treated with combination external beam irradiation and brachytherapyMichael Dattoli, Kent Wallner, Lawrence True, et al.
The Journal of Urology|November 11, 2005
The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledgeGerald Andriole, David Bostwick, Francisco Civantos, et al.
Journal of Chemical Ecology|April 6, 2006
Chemical defenses promote persistence of the aquatic plant Micranthemum umbrosumJohn D Parker, Dwight O Collins, Julia Kubanek, et al.
The Journal of Urology|January 10, 2004
Comprehensive evaluation of ureteral healing after electrosurgical endopyelotomy in a porcine model: original report and review of the literatureCassio R Andreoni, Hsueh-Kung Lin, Ephrem Olweny, et al.
The Journal of Urology|August 8, 2006
Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trialDavid Price, Barry Stein, Paul Sieber, et al.
The Journal of Urology|September 17, 2004
Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trialGerald Andriole, David Bostwick, Otis Brawley, et al.
Pageof 2